大葉大學圖書館 |

Pharmacokinetic and pharmacodynamic drug interactions associated with antiretroviral drugs[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	615.7924
書名/作者:	Pharmacokinetic and pharmacodynamic drug interactions associated with antiretroviral drugs/ edited by Tony K.L. Kiang, Kyle John Wilby, Mary H.H. Ensom.
其他作者:	Kiang, Tony K.L.
出版者:	Singapore : : Springer Singapore :, 2016.
面頁冊數:	vii, 135 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Antiretroviral agents.
標題:	Pharmacokinetics.
標題:	Medicine.
標題:	Pharmacology.
標題:	Infectious diseases.
標題:	Biomedicine.
標題:	Pharmacology/Toxicology.
標題:	Infectious Diseases.
ISBN:	9789811021138
ISBN:	9789811021121
內容註:	1. Introduction -- 2. HIV-Associated Comorbidities -- 3. Pharmacology and Pharmacokinetic Properties of Available Antiretrovirals -- 4. In Vitro Reaction Phenotyping and Drug Interaction Data -- 5. Clinical Drug-Drug Interaction Data: Effects of Co-administered Drugs on Pharmacokinetics of Antiretroviral Agents -- 6. Clinical Drug-Drug Interaction Data: Effects of Antiretroviral Agents on Co-administered Drugs -- 7. Pharmacodynamic Interactions Between Antiretrovirals and Other Agents -- 8. Conclusion and Clinical Decision Algorithm.
摘要、提要註:	Clinically-focussed, with easily accessible tables and chapter summaries suitable for clinicians and researchers, this comprehensive book provides a systematic, critical evaluation of the current literature. An updated clinical decision-making algorithm specifically tailored to the antiretroviral drugs is also provided. The identified interactions are interpreted in the context of known mechanisms derived from clinical, preclinical, and in vitro data. The clinical relevance of the interactions is systematically evaluated and gaps in literature discussed in the context of potential future experiments. In addition to the comprehensive summary of pharmacokinetic and pharmacodynamic drug interactions associated with WHO-recommended antiretroviral drugs on the market today (i.e. nucleotide reverse-transcriptase inhibitors, non-nucleoside reverse-transcriptase inhibitors, integrase inhibitors, and protease inhibitors), this book also provides detailed section summaries on the epidemiology of HIV infection, diagnosis and pharmacotherapy, basic pharmacology of the individual antiretrovirals, pertinent pre-clinical and in vitro molecular pharmacology, and in vitro drug interaction data available in the literature today.
電子資源:	http://dx.doi.org/10.1007/978-981-10-2113-8

Pharmacokinetic and pharmacodynamic drug interactions associated with antiretroviral drugs[electronic resource] /
Pharmacokinetic and pharmacodynamic drug interactions associated with antiretroviral drugs[electronic resource] /edited by Tony K.L. Kiang, Kyle John Wilby, Mary H.H. Ensom. - Singapore :Springer Singapore :2016. - vii, 135 p. :ill., digital ;24 cm.

1. Introduction -- 2. HIV-Associated Comorbidities -- 3. Pharmacology and Pharmacokinetic Properties of Available Antiretrovirals -- 4. In Vitro Reaction Phenotyping and Drug Interaction Data -- 5. Clinical Drug-Drug Interaction Data: Effects of Co-administered Drugs on Pharmacokinetics of Antiretroviral Agents -- 6. Clinical Drug-Drug Interaction Data: Effects of Antiretroviral Agents on Co-administered Drugs -- 7. Pharmacodynamic Interactions Between Antiretrovirals and Other Agents -- 8. Conclusion and Clinical Decision Algorithm.

Clinically-focussed, with easily accessible tables and chapter summaries suitable for clinicians and researchers, this comprehensive book provides a systematic, critical evaluation of the current literature. An updated clinical decision-making algorithm specifically tailored to the antiretroviral drugs is also provided. The identified interactions are interpreted in the context of known mechanisms derived from clinical, preclinical, and in vitro data. The clinical relevance of the interactions is systematically evaluated and gaps in literature discussed in the context of potential future experiments. In addition to the comprehensive summary of pharmacokinetic and pharmacodynamic drug interactions associated with WHO-recommended antiretroviral drugs on the market today (i.e. nucleotide reverse-transcriptase inhibitors, non-nucleoside reverse-transcriptase inhibitors, integrase inhibitors, and protease inhibitors), this book also provides detailed section summaries on the epidemiology of HIV infection, diagnosis and pharmacotherapy, basic pharmacology of the individual antiretrovirals, pertinent pre-clinical and in vitro molecular pharmacology, and in vitro drug interaction data available in the literature today.

ISBN: 9789811021138

Standard No.: 10.1007/978-981-10-2113-8doiSubjects--Topical Terms:

394830
Antiretroviral agents.

LC Class. No.: RC606.7

Dewey Class. No.: 615.7924

Pharmacokinetic and pharmacodynamic drug interactions associated with antiretroviral drugs[electronic resource] /
LDR:02791nam a2200313 a 4500 001 476919
003 DE-He213
005 20161221083443.0
006 m d
007 cr nn 008maaau
008 181208s2016 si s 0 eng d
020 $a 9789811021138 $q (electronic bk.)
020 $a 9789811021121 $q (paper)
024 7 $a 10.1007/978-981-10-2113-8 $2 doi
035 $a 978-981-10-2113-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC606.7
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 615.7924 $2 23
090 $a RC606.7 $b .P536 2016
245 0 0 $a Pharmacokinetic and pharmacodynamic drug interactions associated with antiretroviral drugs $h [electronic resource] / $c edited by Tony K.L. Kiang, Kyle John Wilby, Mary H.H. Ensom.
260 $a Singapore : $b Springer Singapore : $b Imprint: Adis, $c 2016.
300 $a vii, 135 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Introduction -- 2. HIV-Associated Comorbidities -- 3. Pharmacology and Pharmacokinetic Properties of Available Antiretrovirals -- 4. In Vitro Reaction Phenotyping and Drug Interaction Data -- 5. Clinical Drug-Drug Interaction Data: Effects of Co-administered Drugs on Pharmacokinetics of Antiretroviral Agents -- 6. Clinical Drug-Drug Interaction Data: Effects of Antiretroviral Agents on Co-administered Drugs -- 7. Pharmacodynamic Interactions Between Antiretrovirals and Other Agents -- 8. Conclusion and Clinical Decision Algorithm.
520 $a Clinically-focussed, with easily accessible tables and chapter summaries suitable for clinicians and researchers, this comprehensive book provides a systematic, critical evaluation of the current literature. An updated clinical decision-making algorithm specifically tailored to the antiretroviral drugs is also provided. The identified interactions are interpreted in the context of known mechanisms derived from clinical, preclinical, and in vitro data. The clinical relevance of the interactions is systematically evaluated and gaps in literature discussed in the context of potential future experiments. In addition to the comprehensive summary of pharmacokinetic and pharmacodynamic drug interactions associated with WHO-recommended antiretroviral drugs on the market today (i.e. nucleotide reverse-transcriptase inhibitors, non-nucleoside reverse-transcriptase inhibitors, integrase inhibitors, and protease inhibitors), this book also provides detailed section summaries on the epidemiology of HIV infection, diagnosis and pharmacotherapy, basic pharmacology of the individual antiretrovirals, pertinent pre-clinical and in vitro molecular pharmacology, and in vitro drug interaction data available in the literature today.
650 0 $a Antiretroviral agents. $3 394830
650 0 $a Pharmacokinetics. $3 431421
650 0 $a Medicine. $3 373206
650 0 $a Pharmacology. $3 213245
650 0 $a Infectious diseases. $3 652110
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Pharmacology/Toxicology. $3 463455
650 2 4 $a Infectious Diseases. $3 463456
700 1 $a Kiang, Tony K.L. $3 604906
700 1 $a Wilby, Kyle John. $3 604907
700 1 $a Ensom, Mary H.H. $3 604908
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-2113-8
950 $a Biomedical and Life Sciences (Springer-11642)